Advertisement

The Disease-Reservoir Hypothesis

  • Robert M. Kaplan
Chapter

Chapter 1 began with the story of Sally, a 77-year-old woman who had been diagnosed with ductal breast cancer. Sally received aggressive treatment and went on to live a life free of breast cancer. She also suffered from the consequences of the treatment. Not everyone believes that Sally required treatment, but few would advise her against taking action. The suggestion that Sally consider foregoing treatment disturbs many people. However, we do need to ask, what would happen if she consumed, and if we as a nation consumed, less medical care? The question is deceptively simple, but the answer maddeningly difficult.

To attempt an answer, it is best to begin at the beginning. The purpose of healthcare is to improve health. Health outcomes can be defined in terms of only two measurements: quantity of life and quality of life. A successful treatment is one that makes people live longer and/or improves quality of life [1, 2]. If a treatment neither extends life nor improves its quality, we...

Keywords

Breast Cancer Prostate Cancer Chronic Obstructive Pulmonary Disease Thyroid Cancer Autopsy Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kaplan RM, Wingard DL. Trends in breast cancer incidence, survival, and mortality. Lancet.Aug 12 2000;356(9229):592–593.CrossRefGoogle Scholar
  2. 2.
    Kaplan RM. The Ziggy Theorem – toward an Outcomes-Focused Health Psychology. Health Psychol. 1994;13(6):451–460.CrossRefGoogle Scholar
  3. 3.
    Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med.Dec 1 1997;127(11):1023–1028.Google Scholar
  4. 4.
    Welch HG, Schwartz LM, Woloshin S. Do increased 5-year survival rates in prostate cancer indicate better outcomes? JAMA.Oct 25 2000;284(16):2053–2055.CrossRefGoogle Scholar
  5. 5.
    Kaplan RM, Groessl EJ. Cost/effectiveness analysis in behavioral medicine. J Consult Clin Psychol.2002; in press.Google Scholar
  6. 6.
    McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med.Jun 26 2003;348(26):2635–2645.CrossRefGoogle Scholar
  7. 7.
    Epstein AM, Lee TH, Hamel MB. Paying physicians for high-quality care. N Engl J Med.Jan 22 2004;350(4):406–410.CrossRefGoogle Scholar
  8. 8.
    Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA.1999;281(8):727–735.CrossRefGoogle Scholar
  9. 9.
    Gosselaar C, Roobol MJ, Schroder FH. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant? BJU Int.Feb 2005;95(2):231–237.CrossRefGoogle Scholar
  10. 10.
    Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med.1997;127(11):1023–1028.Google Scholar
  11. 11.
    Klingler K. Early dection of lung cancer by CT-screening. Eur J Cancer: ECJ Suppl.2004;2(1):23.CrossRefGoogle Scholar
  12. 12.
    Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst.Aug 16 2000;92(16):1308–1316.CrossRefGoogle Scholar
  13. 13.
    Manolio TA, Burke GL, O'Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol.1999;19(2):356–365.Google Scholar
  14. 14.
    Black WC, Welch HG. Screening for disease. AJR. Am J Roentgenol.1997;168(1):3–11.Google Scholar
  15. 15.
    Kaplan RM. Two pathways to prevention. Am Psychol.Apr 2000;55(4):382–396.CrossRefGoogle Scholar
  16. 16.
    Kaplan RM. Decisions about prostate cancer screening in managed care. Curr Opin Oncol.1997;9(5):480–486.CrossRefGoogle Scholar
  17. 17.
    MacMahon S. Blood pressure and the risk of cardiovascular disease. N Engl J Med.Jan 6 2000;342(1):50–52.CrossRefGoogle Scholar
  18. 18.
    Black WC. Should this patient be screened for cancer? Eff Clin Pract.Mar–Apr 1999;2(2):86–95.Google Scholar
  19. 19.
    Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA.1999;281(5):446–453.CrossRefGoogle Scholar
  20. 20.
    Fye WB. Cardiology workforce: a shortage, not a surplus. Health Aff (Millwood).Jan–Jun 2004;Suppl Web Exclusives:W4-64–W4-66.Google Scholar
  21. 21.
    Bhargavan M, Sunshine JH, Schepps B. Data from a professional society placement service as a measure of the employment market for radiation oncologists. Int J Radiat Oncol Biol Phys.Jun 1 2002;53(2):401–406.CrossRefGoogle Scholar
  22. 22.
    Bhargavan M, Sunshine JH, Schepps B. Too few radiologists? AJR Am J Roentgenol.May 2002;178(5):1075–1082.Google Scholar
  23. 23.
    Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med.Jul 14 1994;331(2):69–73.CrossRefGoogle Scholar
  24. 24.
    Hunold P, Schmermund A, Seibel RM, Gronemeyer DH, Erbel R. Prevalence and clinical significance of accidental findings in electron-beam tomographic scans for coronary artery calcification. Eur Heart J. 2001;22:1748–1758.Google Scholar
  25. 25.
    Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328(17):1237–1243.Google Scholar
  26. 26.
    Kaplan RM, Saltzstein SL. Reduced mammographic screening may explain declines in breast carcinoma in older women. J Am Geriatr Soc.May 2005;53(5):862–866.CrossRefGoogle Scholar
  27. 27.
    Kaplan RM, Ganiats TG, Frosch DL. Diagnostic and treatment decisions in US healthcare. J Health Psychol.Jan 2004;9(1):29–40.CrossRefGoogle Scholar
  28. 28.
    Wennberg JE. The Dartmouth Atlas of Health Care in the United States. Hanover, NH: Trustees of Dartmouth College; 1998.Google Scholar
  29. 29.
    Wennberg JE, Fisher ES, Skinner JS. Geography and the debate over Medicare reform. Health Aff (Millwood).2002;Suppl Web Exclusives:W96–114.Google Scholar
  30. 30.
    Wennberg JE. Small area analysis and the medical care outcome problem. Paper presented at: Research Methodology: Strengthening Causal Interpretations of Nonexperimental Data, 1990; Rockville, MD.Google Scholar
  31. 31.
    Wennberg J, Gittelsohn A. Variations in medical care among small areas. Sci Am.1982;246(4):120–134.CrossRefGoogle Scholar
  32. 32.
    Fisher ES, Wennberg JE, Stukel TA, Sharp S. Hospital readmissions rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med.1994;331(15):989–995.CrossRefGoogle Scholar
  33. 33.
    Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med.Feb 18 2003;138(4):273–287.Google Scholar
  34. 34.
    Smith C, Cowan C, Sensenig A, Catlin A. Health spending growth slows in 2003. Health Aff (Millwood).Jan–Feb 2005;24(1):185–194.CrossRefGoogle Scholar
  35. 35.
    Fisher ES, Welch HG. Could more health care lead to worse health? Hosp Pract (Off Ed). Nov 15 1999;34(12):15–16, 21–12, 25 passim.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Robert M. Kaplan
    • 1
  1. 1.UCLA School of Public HealthLos AngelesUSA

Personalised recommendations